Isaac Haq

Isaac Haq is a Senior Analyst at ArchiMed. Prior to their current role, they were with Polyplus-transfection S.A., CLEAN BIOLOGICS, and ArchiMed. Isaac also spent time as a Junior Analyst with Motive Partners from July 2017 to January 2018. Before that, they were with Biotechspert as a Business Development Junior Analyst from January 2017 to March 2017.

Isaac's research experience includes a role as a Researcher with Polygeia from September 2015 to June 2016 and as an Undergraduate Student Researcher with Lancaster University from June 2013 to September 2013.

Isaac holds a degree in Biology from the University of Edinburgh.

Isaac Haq has a Doctor of Philosophy - PhD in Health Economics & Policy from Lancaster University, a Master of Science - MS in Finance and Private Equity from The London School of Economics and Political Science (LSE), and a BA Medicine with Cognitive Neuroscience from University of Cambridge. Isaac went to Lancaster Royal Grammar School.

Some of their coworkers include Florian Demleitner - Principal, Benedikt Gentner - Associate, and Steffen Brand - Associate. Isaac Haq reports to Ludovic Alonzi, Director, Investment.